Vibegron gemtesa canada approval?

Short answer: As of now, vibegron (Gemtesa) is not approved in Canada.

What that means
- Vibegron is approved for overactive bladder in the U.S. (FDA) and in some other countries, but Health Canada has not granted an approval for vibegron in Canada yet.
- In Canada, the available beta-3 agonist for OAB is mirabegron (brand Myrbetriq), along with various antimuscarinic options.

How to check the current status
- Health Canada Drug Product Database: search for “vibegron” or “Gemtesa” to see if there is any current approval, ongoing submission, or notices.
- Speak with a pharmacist or your healthcare provider for the latest status and any approved alternatives.

If you’re seeking treatment options in Canada, talk to your doctor about:
- Mirabegron (Myrbetriq) as a beta-3 agonist option.
- Antimuscarinic agents (e.g., solifenacin, tolterodine, oxybutynin, darifenacin, fesoterodine) and non-pharmacologic approaches.

Would you like me to guide you through checking Health Canada’s database or discuss alternatives in more detail? If you want real-time status, I can help you look up the latest if you enable me to search the web.